US Stock MarketDetailed Quotes
ALVO Alvotech
- 13.540
- +0.140+1.04%
Close Apr 24 16:00 ET
3.79BMarket Cap-5572P/E (TTM)
13.750High13.470Low191.09KVolume13.550Open13.400Pre Close2.60MTurnover0.22%Turnover RatioLossP/E (Static)279.57MShares18.00052wk High-4.06P/B1.18BFloat Cap6.70052wk Low--Dividend TTM87.07MShs Float18.000Historical High--Div YieldTTM2.09%Amplitude5.200Historical Low13.608Avg Price1Lot Size
About Alvotech Company
Alvotech is a biotechnology company, which engages in the development and manufacture of biosimilar medicines. The firm is focusing on the development of its product candidates. It operates through the following geographical segments: Europe, North America, Asia, and Other. The company was founded by Róbert Vilhelm Wessman on August 23, 2021 and is headquartered in Luxembourg.
Company Profile
SymbolALVO
Company NameAlvotech
Listing DateJun 16, 2022
Founded2018
CEOMr. Robert Wessman
MarketNASDAQ
Employees999
Securities TypeOrdinary Shares
Fiscal Year Ends12-31
Address9, rue de Bitbourg
CityLuxembourg
ProvinceLuxembourg
CountryLuxembourg
Zip Code1273
Phone352-422-4500
Websitehttp://www.alvotech.com
Company Executives
- Name
- Position
- Salary
- Robert Wessman
- Executive Chairman of the Board and Chief Executive Officer
- --
- Joseph E. McClellan
- Chief Scientific Officer
- --
- Joel Morales
- Chief Financial Officer
- --
- Richard Davies
- Deputy Chairman of the Board
- --
- Faysal Kalmoua
- Director
- --
- Linda McGoldrick
- Director
- --
- Lisa Graver
- Director
- --
- Tomas Ekman
- Director
- --
- Ann Merchant
- Director
- --
- Arni Hardarson
- Director
- --
- Zharov Tanya
- General Counsel
- --
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg